244 related articles for article (PubMed ID: 33463090)
1. Targeting cancer metastasis with antibody therapeutics.
Yang H; Kuo YH; Smith ZI; Spangler J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1698. PubMed ID: 33463090
[TBL] [Abstract][Full Text] [Related]
2. Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.
Iiizumi M; Liu W; Pai SK; Furuta E; Watabe K
Biochim Biophys Acta; 2008 Dec; 1786(2):87-104. PubMed ID: 18692117
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy.
Liang C; Xu L; Song G; Liu Z
Chem Soc Rev; 2016 Nov; 45(22):6250-6269. PubMed ID: 27333329
[TBL] [Abstract][Full Text] [Related]
5. Advances in engineering local drug delivery systems for cancer immunotherapy.
Abdou P; Wang Z; Chen Q; Chan A; Zhou DR; Gunadhi V; Gu Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1632. PubMed ID: 32255276
[TBL] [Abstract][Full Text] [Related]
6. Immune Targeting of Tetraspanins Involved in Cell Invasion and Metastasis.
Vences-Catalán F; Levy S
Front Immunol; 2018; 9():1277. PubMed ID: 29946318
[TBL] [Abstract][Full Text] [Related]
7. Rational design of multimodal therapeutic nanosystems for effective inhibition of tumor growth and metastasis.
Wang F; Huang Q; Wang Y; Zhang W; Lin R; Yu Y; Shen Y; Cui H; Guo S
Acta Biomater; 2018 Sep; 77():240-254. PubMed ID: 30012354
[TBL] [Abstract][Full Text] [Related]
8. Emerging nanomedicine-based therapeutics for hematogenous metastatic cascade inhibition: Interfering with the crosstalk between "seed and soil".
Wu J; Long Y; Li M; He Q
Acta Pharm Sin B; 2021 Aug; 11(8):2286-2305. PubMed ID: 34522588
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine as an emerging platform for metastatic lung cancer therapy.
Landesman-Milo D; Ramishetti S; Peer D
Cancer Metastasis Rev; 2015 Jun; 34(2):291-301. PubMed ID: 25948376
[TBL] [Abstract][Full Text] [Related]
10. Immune Regulation of the Metastatic Process: Implications for Therapy.
de Mingo Pulido A; Ruffell B
Adv Cancer Res; 2016; 132():139-63. PubMed ID: 27613132
[TBL] [Abstract][Full Text] [Related]
11. Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer.
Li YJ; Wu JY; Wang JM; Xiang DX
J Control Release; 2020 Apr; 320():105-111. PubMed ID: 31978441
[TBL] [Abstract][Full Text] [Related]
12. Targeted siRNA nanotherapeutics against breast and ovarian metastatic cancer: a comprehensive review of the literature.
Subhan A; Attia SA; P Torchilin V
Nanomedicine (Lond); 2022 Jan; 17(1):41-64. PubMed ID: 34930021
[TBL] [Abstract][Full Text] [Related]
13. Nanobody-A versatile tool for cancer diagnosis and therapeutics.
Liu M; Li L; Jin D; Liu Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1697. PubMed ID: 33470555
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy.
Wang W; Hao Y; Liu Y; Li R; Huang DB; Pan YY
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1654. PubMed ID: 32700465
[TBL] [Abstract][Full Text] [Related]
15. Promise of chemokine network-targeted nanoparticles in combination nucleic acid therapies of metastatic cancer.
Xie Y; Wang Y; Li J; Hang Y; Oupický D
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Mar; 11(2):e1528. PubMed ID: 29700990
[TBL] [Abstract][Full Text] [Related]
16. MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.
Das SK; Maji S; Wechman SL; Bhoopathi P; Pradhan AK; Talukdar S; Sarkar D; Landry J; Guo C; Wang XY; Cavenee WK; Emdad L; Fisher PB
Pharmacol Res; 2020 May; 155():104695. PubMed ID: 32061839
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine-Based Immunotherapy for the Treatment of Cancer Metastasis.
Zhang P; Zhai Y; Cai Y; Zhao Y; Li Y
Adv Mater; 2019 Dec; 31(49):e1904156. PubMed ID: 31566275
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of lymphangiogenesis: targets for blocking the metastatic spread of cancer.
McColl BK; Loughran SJ; Davydova N; Stacker SA; Achen MG
Curr Cancer Drug Targets; 2005 Dec; 5(8):561-71. PubMed ID: 16375662
[TBL] [Abstract][Full Text] [Related]
20. New solid tumor targets for therapeutic monoclonal antibodies.
Papkoff J
Expert Opin Ther Targets; 2007 May; 11(5):585-8. PubMed ID: 17465718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
